## Abstract For Abstract see ChemInform Abstract in Full Text.
Inhibition of human tumour cell proliferation by analogues of adenosine
โ Scribed by Alison Colquhoun; Eric A. Newsholme
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 102 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0263-6484
No coin nor oath required. For personal study only.
โฆ Synopsis
The eects of adenosine and several structural analogues of adenosine upon thymidine incorporation into human tumour cells and rat cervical lymphocytes were investigated. The analogue NECA, which has equal speciยฎcity for the A 1 and A 2 receptor, had the most inhibitory eect on lymphocyte proliferation while the A 1 agonists had limited eects, suggesting that these cells possess principally A 2 adenosine receptors. In the case of human tumour cells, however, the most inhibitory eect on proliferation was obtained with the A 1 -specific analogues. The general order of inhibitory eects of adenosine analogues on thymidine incorporation in human tumour cells was: S-ENBA b CPA R-PIA b S-PIA b NECAX These ยฎndings suggest that in the cells presently studied the A 1 adenosine receptor predominates. Removal of exogenous adenosine by growth in the presence of adenosine deaminase inhibited thymidine incorporation. The eect of adenosine removal lends further support to the proposal that adenosine has some, as yet unidentiยฎed, regulatory role in the control of human tumour cell proliferation.
๐ SIMILAR VOLUMES
Oxytocin (OT) inhibits the proliferation of breast-cancer cells in vitro via a specific G-coupled receptor. To elucidate the intracellular mechanism involved in this biological effect, different G-coupled receptor mediators have been investigated in untreated and OT-treated MDA-MB231 breastcarcinoma
The purpose of the present study was to compare inhibitory effects between AMP579 (a new adenosine analog) and adenosine (Ado) in attenuating an interaction between human neutrophils (PMNs) and cultured human umbilical vein endothelial cells (HUVECs). PMN activation was determined by superoxide anio
CD28 and CTLA-4 are opposing regulators of T cell activation, triggered by the two ligands CD80 and CD86. How these ligands promote either T cell activation via CD28 or inhibition via CTLA-4 is not understood. Using CD80 and CD86 molecules expressed on transfected cells, we have identified a major d